🇪🇸 Spain · EU Public Tender
Suministro de medicamentos exclusivos: Olaparib (LYNPARZA), Osimertinib (TAGRISSO) y Benralizumab (FASENRA). 2ª Prórroga P.N.S.P. 27/2019.
🏛️ Servicio Madrileno de Salud, Hospital Universitario La Paz · 📍 Madrid
1.6M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | AstraZeneca Farmacéutica Spain, S.A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.